Patients' Own Genetically Altered Immune Cells Show Promise In Fighting Blood Cancer

July 20, 2015

BALTIMORE - In recent years, immunotherapy has emerged as a promising treatment for certain cancers. Now this strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable. The results appeared in a study published online today in Nature Medicine.

To read the full news story from www.medschool.umaryland.edu, click here.